Latest Breaking News On - Prnewswire nobelpharma america - Page 1 : comparemela.com

Nobelpharma America Earns 2023 Great Place to Work® Certification™ in U.S.; Focus on Collaboration, Trust, Results

/PRNewswire/ Nobelpharma America, specialists in developing treatments and medical devices for rare diseases, announced it has received certification by.

HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US

/PRNewswire/ Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, and a subsidiary of Nobelpharma Co.,.

FDA approves Nobelpharma's HYFTOR™ (sirolimus topical gel) 0.2%

/PRNewswire/ Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, and a subsidiary of Nobelpharma Co.,.

FDA approves Nobelpharma's HYFTOR™ (sirolimus topical gel) 0.2%

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Nobelpharma America Announces Presence at 2021 Society for Pediatric Dermatology Annual Meeting